Annual CFI
$83.31 M
-$3.89 M-4.46%
31 December 2023
Summary:
Dyne Therapeutics annual cash flow from investing activities is currently $83.31 million, with the most recent change of -$3.89 million (-4.46%) on 31 December 2023. During the last 3 years, it has risen by +$128.97 million (+282.46%). DYN annual CFI is now -4.46% below its all-time high of $87.20 million, reached on 31 December 2022.DYN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$19.40 M
-$30.58 M-273.64%
30 September 2024
Summary:
Dyne Therapeutics quarterly cash flow from investing activities is currently -$19.40 million, with the most recent change of -$30.58 million (-273.64%) on 30 September 2024. Over the past year, it has dropped by -$32.22 million (-251.34%). DYN quarterly CFI is now -137.56% below its all-time high of $51.66 million, reached on 30 September 2022.DYN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$161.87 M
-$32.22 M-24.86%
30 September 2024
Summary:
Dyne Therapeutics TTM cash flow from investing activities is currently -$161.87 million, with the most recent change of -$32.22 million (-24.86%) on 30 September 2024. Over the past year, it has dropped by -$238.22 million (-312.00%). DYN TTM CFI is now -239.06% below its all-time high of $116.40 million, reached on 31 March 2023.DYN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.5% | -251.3% | -312.0% |
| 3 y3 years | +282.5% | -581.3% | +11.5% |
| 5 y5 years | +10000.0% | - | - |
DYN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.5% | +160.4% | -137.6% | +89.2% | -239.1% | +11.5% |
| 5 y | 5 years | -4.5% | +160.4% | -137.6% | +89.2% | -239.1% | +11.5% |
| alltime | all time | -4.5% | +160.4% | -137.6% | +89.2% | -239.1% | +11.5% |
Dyne Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$19.40 M(-273.6%) | -$161.87 M(+24.9%) |
| June 2024 | - | $11.17 M(-106.2%) | -$129.65 M(+4.9%) |
| Mar 2024 | - | -$179.84 M(-786.5%) | -$123.59 M(-248.3%) |
| Dec 2023 | $83.31 M(-4.5%) | $26.20 M(+104.3%) | $83.31 M(+9.1%) |
| Sept 2023 | - | $12.82 M(-25.6%) | $76.35 M(-33.7%) |
| June 2023 | - | $17.23 M(-36.3%) | $115.19 M(-1.0%) |
| Mar 2023 | - | $27.06 M(+40.7%) | $116.40 M(+33.5%) |
| Dec 2022 | $87.20 M | $19.24 M(-62.8%) | $87.20 M(+28.7%) |
| Sept 2022 | - | $51.66 M(+180.1%) | $67.73 M(+412.2%) |
| June 2022 | - | $18.44 M(-963.4%) | $13.22 M(-213.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.14 M(+808.9%) | -$11.65 M(-91.5%) |
| Dec 2021 | -$137.89 M(+202.0%) | -$235.00 K(-91.7%) | -$137.89 M(-24.6%) |
| Sept 2021 | - | -$2.85 M(-55.7%) | -$182.88 M(+1.5%) |
| June 2021 | - | -$6.43 M(-95.0%) | -$180.19 M(+3.7%) |
| Mar 2021 | - | -$128.38 M(+183.9%) | -$173.82 M(+280.7%) |
| Dec 2020 | -$45.66 M(+2672.4%) | -$45.22 M(>+9900.0%) | -$45.66 M(>+9900.0%) |
| Sept 2020 | - | -$156.00 K(+119.7%) | -$438.00 K(+55.3%) |
| June 2020 | - | -$71.00 K(-66.4%) | -$282.00 K(+33.6%) |
| Mar 2020 | - | -$211.00 K | -$211.00 K |
| Dec 2019 | -$1.65 M(+1129.1%) | - | - |
| Dec 2018 | -$134.00 K | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFI year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFI year-on-year change?
- What is Dyne Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFI year-on-year change?
What is Dyne Therapeutics annual cash flow from investing activities?
The current annual CFI of DYN is $83.31 M
What is the all time high annual CFI for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from investing activities is $87.20 M
What is Dyne Therapeutics annual CFI year-on-year change?
Over the past year, DYN annual cash flow from investing activities has changed by -$3.89 M (-4.46%)
What is Dyne Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of DYN is -$19.40 M
What is the all time high quarterly CFI for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from investing activities is $51.66 M
What is Dyne Therapeutics quarterly CFI year-on-year change?
Over the past year, DYN quarterly cash flow from investing activities has changed by -$32.22 M (-251.34%)
What is Dyne Therapeutics TTM cash flow from investing activities?
The current TTM CFI of DYN is -$161.87 M
What is the all time high TTM CFI for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from investing activities is $116.40 M
What is Dyne Therapeutics TTM CFI year-on-year change?
Over the past year, DYN TTM cash flow from investing activities has changed by -$238.22 M (-312.00%)